Menu
Not yet recruiting NCT07070557

High Neutrophil-to-Lymphocyte Ratio and Patients With Hemodialysis

— Observational Hemodialysis Patient

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: neutrophil lymphocyte ratio and platelet lymphocyte ratio.
Who it may be relevant to
Registry conditions: Hemodialysis Patient. Basic parameters: from 18 months · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

High Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Associated With Poor Survival in Patients With Hemodialysis

Overview

To explore the role of neutrophil-to-lymphocyte ratio ( NLR ) and platelet-to-lymphocyte ratio ( PLR ) in predicting mortality in hemodialysis (HD) patients.

Interventions

  • Other neutrophil lymphocyte ratio and platelet lymphocyte ratio
    explore the role of neutrophil-to-lymphocyte ratio ( NLR ) and platelet-to-lymphocyte ratio ( PLR ) in predicting mortality in hemodialysis (HD) patients

Primary outcome measures

  • Mortality [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • All cases with age ≥ 18 years from both sexes female and male, having end-stage renal disease (ESRD), who have been on hemodialysis for at least three months and divided to 4 groups according to the median of NLR and PLR

Exclusion criteria

  • • Patients aged < 18 years old.
  • Patient with autoimmune disease.
  • Patient with liver cirrhosis.
  • Patients with immunodeficiency.
  • Patients with malignancy.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Egypt · 1 center
  • Hemodialysis Unit — Sohag

Identifiers

NCT: NCT07070557 · Soh-Med--25-6-10MS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗